Submitted by Anonymous (not verified) on 5 February 2026 - 11:00
Human medicines European public assessment report (EPAR): Tocilizumab STADA (previously Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
Source: